Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling Journal Article


Authors: Antonelli, A. C.; Binyamin, A.; Hohl, T. M.; Glickman, M. S.; Redelman-Sidi, G.
Article Title: Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling
Abstract: Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer is the only bacterial cancer therapy approved for clinical use. Although presumed to induce T cell-mediated immunity, whether tumor elimination depends on bacteria-specific or tumor-specific immunity is unknown. Herein we show that BCG-induced bladder tumor elimination requires CD4 and CD8 T cells, although augmentation or inhibition of bacterial antigen-specific T cell responses does not alter the efficacy of BCG-induced tumor elimination. In contrast, BCG stimulates long-term tumor-specific immunity that primarily depends on CD4 T cells.We demonstrate that BCG therapy results in enhanced effector function of tumor-specific CD4 T cells, mainly through enhanced production of IFN-γ. Accordingly, BCGinduced tumor elimination and tumor-specific immune memory require tumor cell expression of the IFN-γ receptor, but not MHC class II. Our findings establish that a bacterial immunotherapy for cancer is capable of inducing tumor immunity, an antitumor effect that results from enhanced function of tumor-specific CD4 T cells, and ultimately requires tumor-intrinsic IFN-γ signaling, via a mechanism that is distinct from other tumor immunotherapies. © 2020 National Academy of Sciences. All rights reserved.
Keywords: signal transduction; controlled study; protein expression; drug efficacy; nonhuman; cd8+ t lymphocyte; animal cell; mouse; animal tissue; bcg vaccine; cancer immunotherapy; animal experiment; animal model; cohort analysis; bladder cancer; bladder tumor; immunotherapy; gamma interferon; cd4+ t lymphocyte; tumor cell; tumor immunity; major histocompatibility complex; immunological memory; t cell; bcg; human; female; priority journal; article; disease elimination
Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Volume: 117
Issue: 31
ISSN: 0027-8424
Publisher: National Academy of Sciences  
Date Published: 2020-08-04
Start Page: 18627
End Page: 18637
Language: English
DOI: 10.1073/pnas.2004421117
PUBMED: 32680964
PROVIDER: scopus
PMCID: PMC7414065
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Tobias Martin Hohl
    105 Hohl
  2. Michael Glickman
    110 Glickman